Real World Experience of Prescribing Tenofovir Alafenamide for Chronic Hepatitis B Patients in Germany
J. Petersen(Asklepios Klinik St. Georg), Peter Buggisch(Institute for Interdisciplinary Medicine), Søren Just Christensen(University of Münster), C Dikopoulos(Orthopädische Praxis), Christoph Antoni(Heidelberg University), Ulrich Spengler(University of Bonn), Karl‐Georg Simon(Klinikum Leverkusen), Olaf Degen(Universität Hamburg), Florian van Bömmel(University Hospital Leipzig), Johannes Vermehren, Holger Hinrichsen(Kiel University), Heiner Wedemeyer(Medizinische Hochschule Hannover), Ansgar Rieke(Gemeinschaftsklinikum Mittelrhein), K Wiegand(University Hospital Regensburg), Christian Hoffmann(Hochschule für Angewandte Wissenschaften Kiel), Tobias Müller(University of Cambridge), Kerstin Stein, Markus Cornberg(Medizinische Hochschule Hannover), WP Hofmann(Bayer (Germany)), G Teuber
Cited by 0
Related Papers
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
|New England Journal of Medicine|2014|877
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
|Journal of Hepatology|2016|817
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
|New England Journal of Medicine|2017|565